CD40 and neoplasm: Of note, an excitingprospect in the context of CD40 targeting are bispecific antibodiesrecognizing CD40 and a TAA.225,226 These constructs bringtumor debris in proximity to CD40+ cells, which can takeup, process, and present the tumor antigens, while simultaneouslybeing stimulated via CD40.